K-numberK252612
Device nameINDIGO® Aspiration System – Lightning Flash Aspiration Tubing; INDIGO® Aspiration System – Lightning Bolt Aspiration Tubing
ApplicantPenumbra, Inc.
Product codeQEW
Device classClass II
Decision dateOct 16, 2025
DecisionSubstantially Equivalent
Regulation870.5150
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The INDIGO Aspiration System with Lightning Flash and Lightning Bolt Aspiration Tubing is designed to remove blood clots (thrombi and emboli) from peripheral arteries, veins, and pulmonary vessels using mechanical aspiration. The tubing connects the aspiration catheter to the Penumbra Aspiration Pump to facilitate vacuum-based thrombus removal, with the Lightning Bolt variant providing modulated aspiration by alternating between pump suction and ambient pressure saline.

Technological characteristics

The subject devices are mostly identical in materials and dimensions to the predicate, with the Lightning Bolt variant offering larger tubing diameters and a shorter 12-month shelf-life compared to the predicate's 36 months. Material differences are supported by biocompatibility and shelf-life testing. Both variants use the same sterilization method (ethylene oxide), packaging materials, and single-use disposable design.

Test standards cited

Compliance with IEC 60601-1, IEC 60601-1-2, IEC 60601-1-6, and AIM 7351731 for electrical safety and EMC testing. Biocompatibility testing per ISO standards for cytotoxicity, sensitization, irritation, systemic toxicity, and hemocompatibility. Software verification and validation per FDA guidance on device software functions (June 14, 2023).

Substantial equivalence argument

The subject devices are substantially equivalent to the predicate because they share identical intended use, operating principle, design concept, sterilization and packaging processes. Bench-top testing (dimensional inspection, pressurization, compatibility, durability, valve, and tensile testing) demonstrates equivalent performance. Material differences are supported by biocompatibility data, and the shorter shelf-life for the Bolt variant is justified by accelerated aging studies using the same methods as the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →